Targeting molecular pathway. Activation of oncogenic PTPs, (SHP2, PTP1B and PTP4A3) by growth factor receptors promotes tumorigenesis, growth, survival and metastasis through activating Ras/raf/MAPK and PI3K/Akt pathways in several human cancers. Targeting these phosphatases reduces the tumor formation, growth, survival and metastatic potential.